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A B S T R A C T
Background: Multiple measures are utilized to assess alcohol craving, often interchangeably. Little is known
about the relationship between tonic and phasic craving. This study fills this gap in the literature by examining
the association between tonic levels of alcohol craving and phasic craving for alcohol that is provoked by alcohol
administration.
Methods: Forty-three non-treatment seeking problem drinkers underwent an initial interview and two laboratory
testing sessions, where either alcohol or a saline placebo was administered intravenously. Tonic craving was
assessed via the Penn Alcohol Craving Scale (PACS) and Obsessive Compulsive Drinking Scale (OCDS) at the
initial interview. Phasic craving was assessed during the laboratory sessions (i.e., alcohol and saline adminis-
trations, single blinded) at baseline and at 3 subsequent breath alcohol concentrations (0.02, 0.04, and 0.06 g/
dl).
Results: There was a main effect of PACS in predicting phasic craving across both saline and alcohol adminis-
tration conditions (p < 0.05). The OCDS was predictive of phasic craving when alcohol, but not saline, was
administered (p=0.058); the obsessive subscale (p=0.01), but not the compulsive subscale (p > 0.10), pre-
dicted phasic craving during alcohol, as compared to saline administration.
Conclusion: In sum, tonic craving captured by the OCDS was predictive of phasic craving during alcohol ad-
ministration whereas the PACS more generally captured the increase in phasic craving. Therefore, these mea-
sures of tonic craving may function differently in capturing the experience of phasic craving. Implications for the
utilization of the PACS and OCDS as well as assessments of craving in alcoholism research are discussed.
1. Introduction
The phenomenon of craving for substances of abuse has been long
recognized (Drummond, 2001; Jellinek et al., 1955), however, under-
standing of the clinical utility of craving has grown increasingly over
the past generation. Though definitions vary, craving has broadly been
defined as a desire or strong urge to use a substance (Flannery et al.,
2001). Craving has been implicated in multiple domains, including
prognosis, intervention target, clinical outcome, and notably has been
included as a diagnostic criterion in the latest iteration of the Diagnostic
and Statistical Manual of Mental Disorders (Hasin et al., 2013; Tiffany &
Wray, 2012). However, the experience of craving varies widely both
between and within individuals due to a host of factors including se-
verity of alcohol use, environmental factors, heightened stress, and
withdrawal (Drummond, 2001; Haass-Koffler, Leggio, & Kenna, 2014).
Various methods of assessing alcohol craving have been developed.
Self-report measures of subjective craving capture either longer-term,
tonic craving or in the moment, provoked, phasic craving (Ray,
Courtney, Bacio, & MacKillop, 2013). Tonic measures of craving are, by
nature, retrospective and capture a general subjective experience of
craving over a prescribed time period when craving has not been pro-
voked (Ray, Courtney, et al., 2013). Tonic craving has been predictive
of drinking and treatment outcomes (Bottlender & Soyka, 2004;
Flannery, Poole, Gallop, & Volpicelli, 2003; Oslin, Cary, Slaymaker,
Colleran, & Blow, 2009). The Penn Alcohol Craving Scale (PACS) is a 5-
item measure assessing frequency and severity of craving over the
previous week (Flannery, Volpicelli, & Pettinati, 1999). The PACS
benefits from asking specifically about duration and frequency of
craving, whereas most other measures assess intensity of craving alone,
producing a “composite” craving score (Tiffany & Wray, 2012). Alter-
natively, the Obsessive Compulsive Drinking Scale (OCDS) is a 14-item
measure of alcohol related urges and thoughts that produces two sub-
scales, obsessive and compulsive (Anton, Moak, & Latham, 1995). The
OCDS is based on the notion that alcohol use disorders (AUD) are akin
to obsessive compulsive disorders and thus assesses severity of alcohol-
related urges, obsessive thoughts, and compulsive alcohol use over a
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specified timeframe. The OCDS has high reliability and convergent
validity with other measures of craving, AUD, and alcohol consumption
(Bohn, Barton, & Barron, 1996; Connor, Jack, Feeney, & Young, 2008;
Kranzler, Mulgrew, Modesto-Lowe, & Burleson, 1999; Moak, Anton, &
Latham, 1998; Ray, Courtney, et al., 2013).
Phasic measures of alcohol craving, on the other hand, assess in
vivo, current, state-levels of subjective craving for alcohol. Phasic
craving is often the result of provocation, for example during laboratory
cue-exposure paradigms, and has been shown to predict drinking out-
comes (Drummond & Glautier, 1994; Litt, Cooney, & Morse, 2000). This
dynamic state of craving may fluctuate based on a number of factors,
such as the presence of alcohol related cues or ingestion of alcohol itself
(Ray, Courtney, et al., 2013). The 8-item Alcohol Urge Questionnaire
(AUQ; Bohn, Krahn, & Staehler, 1995) assesses an individual's severity
of craving at the given moment and is frequently used in laboratory
based paradigms that include a craving provocation (e.g. MacKillop,
2006; O'Malley, Krishnan-Sarin, Farren, Sinha, & Kreek, 2002; Ray &
Hutchison, 2007).
While alcohol craving research has a long history in the field, the
relationship between tonic and phasic levels of craving for alcohol,
within the individual, remain poorly understood. This study seeks to
advance the literature by comparing tonic (i.e., PACS and OCDS) and
phasic (i.e., craving during controlled alcohol and saline administration
in the laboratory) craving for alcohol in a sample of non-treatment
seeking drinkers. We hypothesize that tonic craving will predict phasic
craving in the laboratory in response to alcohol administration but not
the saline control condition. The rationale for the hypotheses is that to
the extent tonic and phasic craving are related conceptually, there
should be an association between those assessments within individuals
tested in our study for tonic (i.e., self-reported craving over a longer




A total of 295 problem drinkers from the greater Los Angeles
community completed the in-person screening visit where inclusion
criteria were: (1) 21–65 years of age; (2) endorse problems related to
alcohol use; (3) report drinking ≥48 drinks per month; (4) meet DSM-
IV criteria for alcohol dependence (current, defined as past year).
Exclusion criteria were: (1) currently in or seeking treatment for alcohol
problems; (2) report no alcohol use in the past three weeks; (3) history
of major psychiatric disorder (e.g. psychosis); (4) Clinical Institute
Withdrawal Assessment (CIWA-Ar; Sullivan, Sykora, Schneiderman,
Naranjo, & Sellers, 1989) score≥ 10. Of those, a subset of 43 in-
dividuals were selected for an alcohol administration study based on a
genetic polymorphism of the mu opioid receptor (OPRM1) gene (Ray,
Bujarski, et al., 2013); twenty-three of these participants were AA
homozygotes and the remaining twenty were G-allele carriers. Sample
demographics are presented in Table 1.
2.2. Procedures
Participants responded to online and print advertising by calling the
laboratory to complete a telephone interview. Eligible participants were
invited to an in-person assessment where they provided written in-
formed consent and completed individual differences measures.
Participants then completed a physical examination. Eligible partici-
pants were invited to complete two infusion visits, saline and alcohol,
which were completed in randomized, blind, counterbalanced order at
least one week apart (Ray, Bujarski, et al., 2013).
When participants arrived for infusion sessions, they were breath-
alyzed to confirm a breath alcohol concentration (BrAC) of 0.00 g/dl
and regular smokers were allowed to have a cigarette. In order to
mitigate variability in blood alcohol concentration observed between
individuals, a 5% ethanol solution was administered intravenously
using a formula accounting for sex and weight (Ray, Bujarski, et al.,
2013). Upon reaching each target BrAC, 0.02, 0.04, and 0.06 g/dl, the
infusion rate was reduced in half to maintain constant BrAC level while
participants completed a series of measures. During the saline infusion
visit, measures were administered at 0, 18, 43, and 75min during the
saline infusion, to mirror the approximate time points at which target
BrACs were reached in the alcohol administration session. When par-
ticipants reached a BrAC ≤0.02 g/dl they were permitted to leave
(0.00 g/dl if driving).
2.3. Measures
At the screening visit, a master's level clinician administered the
Structured Clinical Interview for DSM-IV (First, Spitzer, Gibbon, &
Williams, 1995), past 30-day Timeline Follow-Back interview (Sobell,
Sobell, Klajner, Pavan, & Basian, 1986), and the CIWA-Ar (Sullivan
et al., 1989). Self-report measures included: a demographics ques-
tionnaire, the Beck Depression Inventory-II (BDI; Beck, Steer, & Brown,
1993), the Beck Anxiety Inventory (BAI; Beck & Steer, 1993), and the
Fagerström Test of Nicotine Dependence (FTND; Heatherton,
Kozlowski, Frecker, & Fagerstrom, 1991).To assess tonic craving, the
PACS (assessing past week craving; Flannery et al., 1999) and the OCDS
(assessing past year craving; Anton et al., 1995) were completed.
During the infusion visits, the AUQ (Bohn et al., 1995) was completed
as each target BrAC (or matched time point) was reached.
2.4. Data analysis plan
Linear regression models were formulated using PROC Mixed in SAS
9.3, first for the PACS and secondly the OCDS and the two subscales,
where the dependent measure was mean phasic craving, as assessed by
the AUQ. All models were designed with individual intercepts, allowing
for random intercepts, where the within subject variables, BrAC and
Alcohol condition, were Level 1 fixed variables and tonic craving was a
Level 2 variable. Covariates tested in all models included OPRM1 status,
smoking status, BDI, BAI and sex, however, none were significant. The
models examined BrAC, which was used as 4-level, within subject in-
dicator of time (baseline was time-point zero, BrAC=0.02 g/dl was
considered time-point 1, etc.), alcohol condition (alcohol versus saline),
and tonic craving (PACS, OCDS, subscales), and their interactions. The
three-way interaction was then removed from the model if not sig-
nificant.
Table 1
Demographic, substance, and mood variables of the sample (n=43).
Demographics
Age (SD, range) 29.3 (9.5, 21–51)
% Male (N) 74.4 (32)
% Caucasian (N) 69.8 (30)
Substance use variables
Drinks per drinking day (SD) 7.1 (2.9)
Drinking days (SD)a 19.2 (7.5)
Total number DSM-IV AUD symptoms (SD) 6.5 (2.3)
CIWA (SD) 5.6 (4.4)
% Daily smokers (N) 32.56 (14)
FTND (SD) 2.2 (2.8)
Alcohol craving
PACS (SD) 15.0 (6.2)
OCDS (SD) 20.6 (9.2)
OCDS-Obsessive (SD) 8.8 (5.2)
OCDS-Compulsive (SD) 11.8 (4.7)
Mood variables
BDI (SD) 18.9 (12.8)
BAI (SD) 15.7 (12.5)
a Drinking days was assessed using the past 30-day TLFB interview
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3. Results
AUQ scores were greater when participants received alcohol com-
pared to placebo, supporting a main effect of alcohol administration on
phasic levels of craving (p < 0.05; Ray, Bujarski, et al., 2013). Results
for the PACS indicated that tonic craving by the PACS had a significant
simple effect (β=0.06, SE=0.03, p=0.04), such that regardless of
alcohol condition higher PACS scores predict higher AUQ scores
(Table 2). There were also simple effects of alcohol condition and time
such that AUQ scores were higher when alcohol was administered
compared to saline and as BrAC increased.
Models using the OCDS as an indicator of tonic craving revealed a
trend level interaction of OCDS× condition (F= 3.62, p=0.058). To
further investigate this effect, the model was tested in each condition.
Results indicate the OCDS was predictive of phasic craving during the
alcohol administration (β=0.05, SE=0.03, p=0.05) but not during
saline (β=0.02, SE= 0.03, p > 0.10). In probing OCDS subscales,
results indicated that the obsessive subscale was driving these effects
such that there was a significant interaction of obsessive subscale with
condition (F=6.17, p=0. 01) such that craving was predictive of
phasic craving during alcohol administration (β=0.11, SE= 0.05,
p=0.02) but not during saline (β=0.04, SE=0.05, p > 0.10). These
effects were not observed for the compulsive subscale of the OCDS
(F= 0.75, p > 0.10).
4. Discussion
Despite the long recognition of alcohol craving as a critical phe-
nomenon in AUD, little is known about the relationship between tonic
and phasic craving levels. Results from this study indicated that the
PACS did not predict phasic craving in response to alcohol adminis-
tration. However, there was a main effect of PACS such that higher
tonic craving was predictive of higher phasic craving, regardless of
whether alcohol or saline was administered. On the other hand, the
OCDS was predictive of phasic craving when alcohol was administered,
but not during the saline administration; similarly, the Obsessive sub-
scale, but not the Compulsive subscale, was predictive of phasic craving
when alcohol was administered. Thus, tonic craving, as assessed by the
OCDS, may be more sensitive to phasic craving that is provoked by
alcohol administration (but not saline), whereas the PACS appears to
generally predict increased phasic craving, regardless of presence of
alcohol. These findings suggest that these measures of tonic craving
may function differently.
Overall, the OCDS is based on the theory that addictive disorders are
similar to obsessive-compulsive disorders and focuses on alcohol re-
lated cognitions and urges. Such cognitions, measured by the obsessive
subscale, may be heightened when alcohol is present. However, data
are mixed regarding the concurrent validity of the OCDS. One study of
alcohol dependent patients did not find any relation of the OCDS to
other measures of alcohol use (Connor et al., 2008). Additionally,
Kranzler et al. (1999) questioned the predictive validity of the OCDS as
it did not strongly predict drinking after completion of a pharma-
cotherapy trial. In contrast, the PACS has shown unique prognostic
utility in predicting number of standard drinks after treatment, above
the effects of the AUQ (Flannery et al., 2003). In this study, higher PACS
score generally predicted higher phasic response but such response was
not different based on alcohol condition, perhaps speaking to the gen-
eral ability of this measure to capture a broader dimension of craving.
The relationship between tonic and phasic craving is clinically re-
levant as both types of craving have shown to predict drinking beha-
viors. Interventions targeting tonic craving may in turn dampen phasic
response to alcohol administration or cues, thus assessing craving in
multidimensional fashion and accounting for combined phasic and
tonic effects appears warranted. To that end, a recent human laboratory
study found that a novel neuroimmune medication (ibudilast) reduced
tonic craving compared to placebo (captured by the PACS) yet there
were no medication effects on alcohol- or cue-induced phasic craving
(Ray et al., 2017). This serves to illustrate the complex clinical interplay
between tonic and phasic craving and its treatment implications.
These results should be interpreted in light of study strengths and
limitations. Strengths include the experimental manipulation where
participants completed both alcohol and placebo administration ses-
sions. Limitations include the small sample size and the fact that
craving could have been dampened during the infusion due to lack of
other cues (e.g. taste, visual). Future studies should examine relation-
ships between tonic and phasic craving using other craving provoca-
tions, such as cue and stress exposure paradigms. Though participants
were included based on OPRM1 status, which has been related to
subjective response, data regarding the association of this poly-
morphism to craving has been mixed (Ray, 2011; Ray, Bujarski, et al.,
2013) and inclusion as a covariate did not impact the findings presented
herein. Though it appears craving has a strong genetic component
(Enoch, 2013; Kimura & Higuchi, 2011), it is unlikely the experience of
craving is attributable to a single genetic variant. Lastly, the intersec-
tion between tonic and phasic craving assessments could be further
elucidated using ecological momentary assessment (EMA) approaches.
In conclusion, this study provides an initial evaluation of the associa-
tion between tonic and phasic subjective craving for alcohol in the
clinic and in the laboratory and finds that while the association was
significant, it is clear that most of the variance between tonic and
phasic measures of alcohol craving are non-shared.
Funding: This study was supported by grants from ABRMF, the
Foundation for Alcohol Research, and the UCLA Clinical and
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